Vivmark director granted 18,559 stock options
Vivmark Residential (VMRK) reported that director David J. Neithercut received a grant of 18,559 non-qualified stock options to buy Common Shares of Beneficial Interest.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Vivmark Residential (VMRK) reported that director David J. Neithercut received a grant of 18,559 non-qualified stock options to buy Common Shares of Beneficial Interest. The options have an exercise price of $63.66 per share, become exercisable on August 17, 2027, and expire on August 17, 2036. The grant represents compensation for prospective service from August 17, 2026 through the 2027 Annual Meeting of Shareholders, and Neithercut now holds 18,559 options directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-qualified Stock Option (Right to Buy) F1 | 18,559 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents share options granted for prospective service from August 17, 2026 to the 2027 Annual Meeting of Shareholders.
Key Figures
Key Terms
Non-qualified Stock Option financial
exercise price financial
expiration date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Vivmark Residential (VMRK) report for David J. Neithercut?
What is the exercise price of the options granted to the VMRK director?
When do David J. Neithercut’s Vivmark Residential (VMRK) options become exercisable?
When do the newly granted Vivmark Residential (VMRK) options expire?
How many Vivmark Residential (VMRK) options does David J. Neithercut hold after this grant?
What service period is covered by the VMRK stock option grant to the director?
AI-generated analysis. How Rhea-AI works. Not financial advice.